ALEXANDER MARGARET A. 4
4 · Ovid Therapeutics Inc. · Filed Jan 5, 2026
Insider Transaction Report
Form 4
ALEXANDER MARGARET A.
DirectorPresident and CEO
Transactions
- Award
Employee Stock Option (right to buy)
2026-01-04+890,000→ 890,000 totalExercise: $1.76Exp: 2036-01-03→ Common Stock (890,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the Stock Option will vest and become exercisable on January 1, 2027 and the remaining shares will vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continued services through such date.